Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ann Jabra-Rizk

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
FEMS Yeast Research|May 25, 2010
Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infectionBrian M Peters, Jingsong Zhu, Paul L Fidel, et al.
Virulence|July 9, 2019
<i>Candida albicans</i> quorum-sensing molecule farnesol modulates staphyloxanthin production and activates the thiol-based oxidative-stress response in <i>Staphylococcus aureus</i>Taissa Vila, Eric F Kong, Ahmed Ibrahim, et al.
Infection and Immunity|July 20, 2016
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response FrameworkMary Ann Jabra-Rizk, Eric F Kong, Christina Tsui, et al.
Plos One|April 9, 2009
A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptideTimothy F Meiller, Bernhard Hube, Lydia Schild, et al.
Plos One|December 30, 2011
Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathioneJingsong Zhu, Bastiaan P Krom, Dominique Sanglard, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 2014
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilmsAspasia Katragkou, Matthew McCarthy, Elizabeth L Alexander, et al.
Frontiers in Microbiology|April 8, 2020
The Role of <i>Candida albicans</i> Secreted Polysaccharides in Augmenting <i>Streptococcus mutans</i> Adherence and Mixed Biofilm Formation: <i>In vitro</i> and <i>in vivo</i> StudiesZaid H Khoury, Taissa Vila, Taanya R Puthran, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 29, 2022
The oral mycobiome: Oral epithelial dysplasia and oral squamous cell carcinomaVasileios Ionas Theofilou, Areej Alfaifi, Daniel Montelongo-Jauregui, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral CandidiasisEric F Kong, Christina Tsui, Heather Boyce, et al.
Microorganisms|July 27, 2024
Oral Microbiota Alterations in Subjects with SARS-CoV-2 Displaying Prevalence of the Opportunistic Fungal Pathogen <i>Candida albicans</i>Areej A Alfaifi, Johanna B Holm, Tristan W Wang, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
FEMS Yeast Research|May 25, 2010
Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infectionBrian M Peters, Jingsong Zhu, Paul L Fidel, et al.
Virulence|July 9, 2019
<i>Candida albicans</i> quorum-sensing molecule farnesol modulates staphyloxanthin production and activates the thiol-based oxidative-stress response in <i>Staphylococcus aureus</i>Taissa Vila, Eric F Kong, Ahmed Ibrahim, et al.
Infection and Immunity|July 20, 2016
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response FrameworkMary Ann Jabra-Rizk, Eric F Kong, Christina Tsui, et al.
Plos One|April 9, 2009
A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptideTimothy F Meiller, Bernhard Hube, Lydia Schild, et al.
Plos One|December 30, 2011
Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathioneJingsong Zhu, Bastiaan P Krom, Dominique Sanglard, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 2014
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilmsAspasia Katragkou, Matthew McCarthy, Elizabeth L Alexander, et al.
Frontiers in Microbiology|April 8, 2020
The Role of <i>Candida albicans</i> Secreted Polysaccharides in Augmenting <i>Streptococcus mutans</i> Adherence and Mixed Biofilm Formation: <i>In vitro</i> and <i>in vivo</i> StudiesZaid H Khoury, Taissa Vila, Taanya R Puthran, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 29, 2022
The oral mycobiome: Oral epithelial dysplasia and oral squamous cell carcinomaVasileios Ionas Theofilou, Areej Alfaifi, Daniel Montelongo-Jauregui, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral CandidiasisEric F Kong, Christina Tsui, Heather Boyce, et al.
Microorganisms|July 27, 2024
Oral Microbiota Alterations in Subjects with SARS-CoV-2 Displaying Prevalence of the Opportunistic Fungal Pathogen <i>Candida albicans</i>Areej A Alfaifi, Johanna B Holm, Tristan W Wang, et al.
Pageof 8